Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.587%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 31.75
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholdings

8 Mar 2018 07:00

RNS Number : 0490H
Duke Royalty Limited
08 March 2018
 

8 March 2018

Duke Royalty Limited("Duke Royalty", "Duke" or the "Company")

 

Director/PDMR Shareholding

 

Duke Royalty Limited (AIM: DUKE) was informed yesterday, 7 March 2018 that on that day directors of the Company bought Duke Royalty ordinary shares of no par value ("Ordinary Shares")  as follows:

Shareholder

Number of Ordinary Shares acquired

Price paid per Ordinary Share

Neil Johnson

125,000

40 pence

Charlie Cannon-Brookes

427,000

39.72 pence

Arlington Group Asset Management Limited

45,193

39.99 pence

Nigel Birrell

125,000

40 pence

Justin Cochrane

50,000

40 pence

 

Charlie Cannon-Brookes is a director and shareholder of Arlington Group Asset Management Limited, Following the purchases of these shares the total holdings and percentages of the voting rights of the Company are as follows:

Shareholder

Number of Ordinary Shares

Percentage of issued share capital

Neil Johnson

1,637,000

1.69%

Charlie Cannon-Brookes

2,500,000

2.58%

Arlington Group Asset Management Limited

2,500,000

2.58%

Nigel Birrell

650,000

0.67%

Justin Cochrane

740,000

0.76%

 

Neil Johnson's holding when aggregated with the RBK&C Trust and Abingdon Capital Corporation (of which he is a director and shareholder) equates to 3,207,193 shares or 3.31 per cent. of the voting rights of the Company.

Charlie Cannon-Brookes' holding when aggregated with Arlington Group Asset Management Limited equates to 5,000,000 shares or 5.16 per cent. of the voting rights of the Company.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited provides alternative financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

Duke Royalty is listed on the AIM market under the ticker DUKE. For more information, visit dukeroyalty.com.

 

For further information:

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson / Samantha Harrison

+44 (0) 20 7383 5100

Cenkos Securities plc (Joint Broker)

Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 (0) 20 3167 7222

Redleaf Communications (PR)

Elisabeth Cowell/ Robin Tozer/ Ian Silvera

+44 (0) 20 3757 6880

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Neil Johnson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

Identification code

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

40p

125,000

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

7 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Charles Cannon-Brookes

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

Identification code

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Charles Cannon-Brookes

39.72p

427,000

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

7 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Arlington Group Asset Management Limited (of which Charles Cannon-Brookes, a director of the Company, is a director and shareholder)

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Connected with an Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

Identification code

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Arlington Group Asset Management Limited

39.99p

45,193

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

7 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nigel Birrell

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Chairman

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

Identification code

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Arlington Group Asset Management Limited

40p

125,000

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

7 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Justin Cochrane

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

Identification code

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Arlington Group Asset Management Limited

40p

50,000

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

7 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGFGNMGRZZ
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.